Clinical Trials Browser

Phase 2 × Carcinoma, Medullary × Irinotecan × Clear all

NCT00100828 2018-12-06

Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer

Phase 2 Terminated

6 enrolled 4 charts

Head and Neck Neoplasms, Thyroid Neoplasms, Carcinoma, Medullary